DOMPE' BIOTEC S

echinoidclapΒιοτεχνολογία

1 Δεκ 2012 (πριν από 4 χρόνια και 7 μήνες)

280 εμφανίσεις



DOMPÉ BIOTEC S.p.A.





GENERAL INFORMATION

Company:
DOMPÉ BIOTEC S.p.A.

Group:
DOMPÉ

Address:
via San Martino 12

City/code:
Milano 20122

Website:
http://www.dompe.it

E
-
mail:
info@dompe.it

Market area:
therapeutics for

onco
-
haematology, nephrolo
gy, CNS

Staff (in biotech
-
related activities):
100 (R&D)

Interest/activity in biotechnology started in (year):
1988

Location of biotechnology lab/plant(s):
L’Aquila

Collaboration/joint venture agreements in biotech with:
Amgen, Ortho Pharmaceuticals,

Biogen,
Cephalon, Genzyme

Companies within the Group with interests in biotechnology:
DOMPÉ S.p.A.


INTEREST/ACTIVITY IN BIOTECHNOLOGY

Application field:
human pharmaceuticals

Technologies:
recombinant DNA, monoclonal antibodies, fermentation, purific
ation/separation,
molecular design & engineering

DESCRIPTION OF PROJECTS AT R&D OR PILOT SCALE STAGE

1.

Chemokine inhibitors

2.

Fully human Fab fragments for cancer radioimmunotherapy

DESCRIPTION OF PRODUCTS & SERVICES

Manufacture & marketing of erythropoie
tin alfa (Globuren), G
-
CSF (Neupogen), gamma
-
interferon
(gammakine), beta
-
interferon (Avonex), darbepoetin alfa (Nespo), sevelamer (Renagel), modafinil
(Provigil)

ADDITIONAL INFORMATION

Licensing and innovation activities through Dompé International S.A
.